16-66988822-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001364782.1(CES4A):c.50C>T(p.Thr17Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000153 in 1,566,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001364782.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CES4A | NM_001364782.1 | c.50C>T | p.Thr17Met | missense_variant | 1/14 | ENST00000648724.3 | NP_001351711.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CES4A | ENST00000648724.3 | c.50C>T | p.Thr17Met | missense_variant | 1/14 | NM_001364782.1 | ENSP00000497868 | P1 | ||
CES4A | ENST00000540947.6 | c.50C>T | p.Thr17Met | missense_variant | 1/12 | 2 | ENSP00000444052 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000339 AC: 6AN: 177250Hom.: 0 AF XY: 0.0000105 AC XY: 1AN XY: 95072
GnomAD4 exome AF: 0.0000141 AC: 20AN: 1414442Hom.: 0 Cov.: 30 AF XY: 0.00000715 AC XY: 5AN XY: 699436
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152346Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74494
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.50C>T (p.T17M) alteration is located in exon 1 (coding exon 1) of the CES4A gene. This alteration results from a C to T substitution at nucleotide position 50, causing the threonine (T) at amino acid position 17 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at